Article PDF
References
Vine AK, Samama MM . The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993;37:283–92.
Lowe GDO . Blood rheology in arterial disease. Clin Sci 1986;71:137–46.
Lip GYH, Beevers DG . Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens 1994;8:693–702.
Ernst E, Resch KL . Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956–63.
Lip GYH . Fibrinogen and cardiovascular disease. Q J Med 1995;88:155–65.
Lip GYH, Blann AD . von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995;74:580–3.
Lip GYH, Lowe GDO . Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995;89:205–14.
Lip GYH, Jones AF . Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis. Q J Med 1995;88:529–39.
Wu KK . Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1996;239:17.
Blann AD, Dobrotova M, Kubisz P, McCollum CN . von Willebrand factor, soluble P-selectin, tissue plasminogen activator inhibitor in atherosclerosis. Thromb Haemostat 1995;74:626–30.
Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Boisseau M . Plasma thrombomodulin: a new approach of endothelial damage. Int Angio 1993;12:355–9.
Lavin MJ, Dhillon BJ . Cyclic variation in onset of CRVO. Br J Ophthalmol 1987;71:18–20.
Woodhouse P, Khaw KT, Meade TW, Stirling Y, Plummer M . Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343:435–9.
Klein BA . Occlusion of the central retinal vein: clinical importance of certain histo-pathologic observations. Am J Ophthalmol 1953;36:316–24.
Rabinowicz IM, Litman S, Michaelson IC . Branch venous thrombosis: a pathological report. Trans Ophthalmol Soc UK 1968;88:191–210.
Smit RL, Baarsma GS, Koudstaal PJ . The source of embolism in amaurosis fugax and retinal artery occlusion. Int Ophthalmol 1994;18:83–6.
Rath EZ, Frank RN, Shin DH, Kim C . Risk factors for retina] vein occlusions: a case-control study. Ophthalmology 1992;99:509–14.
Dodson PM, Kritzinger EE . Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 1985;104:114–9.
Appiah AP, Trempe CL . Risk factors associated with branch vs central retinal vein occlusion. Ann Ophthalmol 1989;21:153–7.
Greven CM, Slusher MM, Weaver RG . Retinal arterial occlusions in young adults. Am J Ophthalmol 1995;120:776–83.
Snyers B, Serckx JP . [Occlusion of the central retinal vein in young adults: risk factors and visual prognosis]. Bull Soc Beige Ophthalmol 1993;250:51–8 (in French).
Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S . Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 1996;103:80–6.
Mansour AM, Walsh JB, Henkind P . Mortality and morbidity in patients with central retinal vein occlusion. Ophthalmologica 1992;204:199–204.
Hankey GJ, Slattery JM, Warlow CP . Prognosis and prognostic factors of retinal infarction: a prospective cohort study. BMJ 1991;302:499–504.
Bandello F, Vigano D'Angelo S, Parlavecchia M, et al. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994;72:39–43.
Pimenov IV, Zaitseva NS, Volkolakova RL [Hemostasis in patients with diseases of the retina and uveal tract]. Vestnik Oftalmologii 1992;108:27–30 (in Russian).
Piermarocchi S, Segato T, Bertoja H, et al. Branch retinal vein occlusion: the pathogenic role of blood viscosity. Ann Ophthalmol 1990;22:303–11.
Glacet-Bernard A, Chabanel A, Lelong F, Samama MM, Coscas G . Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology 1994;101:1483–7.
Williamson TH, Rumley A, Lowe GDO . Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996;80:203–8.
Wiek J, Krause M, Schade M, Wiederholt M, Hansen LL . Haemorheological parameters in patients with retinal artery occlusion and anterior ischaemic optic neuropathy. Br J Ophthalmol 1992;76:142–5.
Wiek J, Schade M, Wiederholt M, Arntz HR, Hansen LL . Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution. Br J Ophthalmol 1990;74:665–9.
Fowkes FGR, Lowe GDO, Housley E, Rattray A, Rumley A, Elton RA, MacGregor IR, Dawes J . Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84–6.
Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ . Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236–40.
Lowe GDO, Rumley A, Yarnell JWG, Sweetnam PM, Thomas HF . Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease: the Caerphilly study. Blood Coag Fibrinolys 1995;6:156–7.
Muller HM, Diekstall FF, Schmidt E, Marz W, Canzler H, Demeler U . Lipoprotein (a): a risk factor for retinal vascular occlusion. Ger J Ophthalmol 1992;1:338–41.
Tavola A, D'Angelo SV, Bandello F, et al. Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein (a) levels: a case report. Thromb Res 1995;80:327–31.
Glacet-Bernard A, Bayani N, Chretien P, Cochard C, Lelong F, Coscas G . Antiphospholipid antibodies in retinal vascular occlusion: a prospective study of 75 patients. Arch Ophthalmol 1994;112:790–5.
Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF . Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 1993:162–7.
Murray PI, Young DW, Aggarwal RK, Blann AD . Von Willebrand factor, endothelial damage and ocular disease. Ocular Immunol Inflamm 1993;1:315–22.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lip, P., Blann, A., Jones, A. et al. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk. Eye 12, 245–251 (1998). https://doi.org/10.1038/eye.1998.58
Issue Date:
DOI: https://doi.org/10.1038/eye.1998.58
This article is cited by
-
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis
BMC Ophthalmology (2014)
-
Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study
Graefe's Archive for Clinical and Experimental Ophthalmology (2011)
-
Morbiditätsrate bei Durchblutungsstörungen am Auge
Spektrum der Augenheilkunde (2002)
-
Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source
Eye (2001)